ECCC Dubai vs Mechanical Ventilation Expert

Dear Friends and Colleagues, On behalf of the ECCC organizing and Scientific Committee, I take this privilege to announce the 22nd edition of the “Emirates Critical Care Conference” (ECCC), 8 – 10 May 2026, at InterContinental Hotel, Event Centre, Dubai Festival City, UAE. The conference is held: In Parallel to: 3rd World Summit of the World Federation of Intensive and Critical Care (WFICC) The 17th Asia Africa Conference of the World Federation of Intensive and Critical Care (WFICC) In Collaboration with: The 8th Conference of Emirates Nursing Association (ENA) Critical Care Chapter 21st World Federation of Critical Care Nurses (WFCCN) World Congress In Conjunction with: The 7th Regional Neurocritical Care Society Meeting (NCS) MENA Chapter The 22nd International Pan Arab Critical Care Medicine Society (IPACCMS) Conference Building on our legacy of excellence, ECCC 2026 continues to bridge East and West, fostering collaboration, innovation and shared learning in critical care medicine. This year’s theme, “From Evidence to Excellence: The Future of Critical Care”, reflects our commitment to advancing patient outcomes through global knowledge exchange and multidisciplinary expertise. Over the three days of the conference, you will experience a diverse and enriching scientific program — including keynote sessions, hands-on workshops and interactive discussions — all designed to enhance clinical expertise and promote best practices. In conjunction with the conference, leading companies from across the globe will showcase their latest medical products, technologies and equipment, offering attendees a unique opportunity to explore cutting-edge innovations in critical care. Participants will also have the chance to attend industry-led sessions and talks by world-renowned experts, providing valuable insights into emerging trends and advancements in the field. We extend our heartfelt gratitude to our esteemed faculty, industry partners and participants for your continued support and contribution in making ECCC a cornerstone event in the critical care calendar. We trust that this remarkable event will inspire and benefit all professionals and colleagues dedicated to the field of Critical Care and Emergency Medicine. The conference is organized by InfoPlus Events and will be accredited by the Dubai Health Authority (DHA). Assoc. Prof. Dr. Hussain Al Rahma Founding Chairperson of the conference (ECCC-Dubai) Secretary General of World Federation of Intensive and Critical Care (WFICC) Founding President of Emirates Intensive Care Society (EICS) President International Pan-Arab Critical Care Medicine Society (IPACCMS) Board member Emirates Resuscitation Council Head of Department (Emergency & Critical Care), Emirates Hospitals Group United Arab Emirates

Caution! This app is intended for intensive care physicians. If you are NOT a physician and would like to use it anyway, please consult your physician before using this app or making any medical decisions. This app has endorsement for usage in the Russian Federation. Many doctors deal with the treatment of patients with varying degrees of acute respiratory failure (ARF). But the choice of the optimal method and, especially, the timely correction of the parameters of invasive and non-invasive mechanical lung ventilation often cause difficulties, especially for young doctors. Unfortunately, expensive ventilation machines, without their skillful use, are not a guarantee of an improvement in the mortality rate in ARF. This has been especially evident during the COVID-19 pandemic. In international clinical practice, it is customary to determine the degree of ARF by the oxygenation index (the ratio of the partial pressure of oxygen in arterial blood (PaO2) to the fraction of inspired oxygen (FiO2)). This indicator is also included in most "severity of illness" scoring systems (SOFA, APACHE II-III, etc.). However PaO2 estimation is only possible after collecting the arterial blood for laboratory monitoring of blood gases, making it costly and invasive. In 2020-2021 a multicenter research was carried out at five clinical hospitals in Volgograd, Russia, which included 1038 patients with acute lung injury and acute respiratory distress syndrome against the background of viral (COVID-19) and bacterial pneumonia. The goals of the research were firstly, to develop a non-invasive method for determining the oxygenation index (PaO2 / FiO2) based on oxygen saturation (SpO2), and secondly, to define general criteria for correcting the parameters of invasive and non-invasive mechanical ventilation. This application is based on the results of the research. The relationship between SpO2 and PaO2 index values was determined for various FiO2 and types of respiratory support. The app also implements the general principle of oxygen therapy - from less to more invasive. The app allows the user not only to choose the most effective method of respiratory support, but also timely learn about the need for its correction. Every clinician knows that the mortality rate in patients with ARF is greatly influenced by the validity of the beginning and end of Invasive Mechanical Ventilation treatment - and this app solves this problem. The educational effect of this app should also be noted. It will help doctors to quickly master and more competently use expensive ventilation machines, which, of course, will have a beneficial effect on the results of treatment of patients with ARF. The following sources were used to create the app: 1. Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou PC, Thompson BT, Brower RG; NIH/NHLBI PETAL Network Collaborators. Nonlinear Imputation of Pao2/Fio2 From Spo2/Fio2 Among Patients With Acute Respiratory Distress Syndrome. Chest. 2016 Aug;150(2):307-13. doi: 10.1016/j.chest.2016.01.003. Epub 2016 Jan 19. PMID: 26836924; PMCID: PMC4980543. 2. Bilan N, Dastranji A, Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the pao2/fio2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J Cardiovasc Thorac Res. 2015;7(1):28-31. doi: 10.15171/jcvtr.2014.06. Epub 2015 Mar 29. PMID: 25859313; PMCID: PMC4378672. 3. Yoshida T, Takegawa R, Ogura H. [Ventilatory strategy for ARDS]. Nihon Rinsho. 2016 Feb;74(2):279-84. Japanese. PMID: 26915253. 4. Fan E, Brodie D, Slutsky AS. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018 Feb 20;319(7):698-710. doi: 10.1001/jama.2017.21907. PMID: 29466596. 5. Петров, В. И. Эволюция клинико-фармакологических и терапевтических принципов лечения инфекции COVID-19 / Петров В. И. [и др. ]. - Москва : ГЭОТАР-Медиа, 2021. - 312 с. - DOI: 10.33029/9704-6386-4-ECPC-2021-1-312. - ISBN 978-5-9704-6386-4.